Hamada Yohhei, Quartagno Matteo, Law Irwin, Malik Farihah, Bonsu Frank Adae, Adetifa Ifedayo M O, Adusi-Poku Yaw, D'Alessandro Umberto, Bashorun Adedapo Olufemi, Begum Vikarunnessa, Lolong Dina Bisara, Boldoo Tsolmon, Dlamini Themba, Donkor Simon, Dwihardiani Bintari, Egwaga Saidi, Farid Muhammad N, Celina G Garfin Anna Marie, Mae G Gaviola Donna, Husain Mohammad Mushtuq, Ismail Farzana, Kaggwa Mugagga, Kamara Deus V, Kasozi Samuel, Kaswaswa Kruger, Kirenga Bruce, Klinkenberg Eveline, Kondo Zuweina, Lawanson Adebola, Macheque David, Manhiça Ivan, Maama-Maime Llang Bridget, Mfinanga Sayoki, Moyo Sizulu, Mpunga James, Mthiyane Thuli, Mustikawati Dyah Erti, Mvusi Lindiwe, Nguyen Hoa Binh, Nguyen Hai Viet, Pangaribuan Lamria, Patrobas Philip, Rahman Mahmudur, Rahman Mahbubur, Rahman Mohammed Sayeedur, Raleting Thato, Riono Pandu, Ruswa Nunurai, Rutebemberwa Elizeus, Rwabinumi Mugabe Frank, Senkoro Mbazi, Sharif Ahmad Raihan, Sikhondze Welile, Sismanidis Charalambos, Sovd Tugsdelger, Stavia Turyahabwe, Sultana Sabera, Suriani Oster, Thomas Albertina Martha, Tobing Kristina, Van der Walt Martie, Walusimbi Simon, Zaman Mohammad Mostafa, Floyd Katherine, Copas Andrew, Abubakar Ibrahim, Rangaka Molebogeng X
Institute for Global Health, University College London, United Kingdom.
MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, United Kingdom.
EClinicalMedicine. 2023 Aug 30;63:102191. doi: 10.1016/j.eclinm.2023.102191. eCollection 2023 Sep.
Non-communicable diseases (NCDs) and NCD risk factors, such as smoking, increase the risk for tuberculosis (TB). Data are scarce on the risk of prevalent TB associated with these factors in the context of population-wide systematic screening and on the association between NCDs and NCD risk factors with different manifestations of TB, where ∼50% being asymptomatic but bacteriologically positive (subclinical). We did an individual participant data (IPD) meta-analysis of national and sub-national TB prevalence surveys to synthesise the evidence on the risk of symptomatic and subclinical TB in people with NCDs or risk factors, which could help countries to plan screening activities.
In this systematic review and IPD meta-analysis, we identified eligible prevalence surveys in low-income and middle-income countries that reported at least one NCD (e.g., diabetes) or NCD risk factor (e.g., smoking, alcohol use) through the archive maintained by the World Health Organization and by searching in Medline and Embase from January 1, 2000 to August 10, 2021. The search was updated on March 23, 2023. We performed a one-stage meta-analysis using multivariable multinomial models. We estimated the proportion of and the odds ratio for subclinical and symptomatic TB compared to people without TB for current smoking, alcohol use, and self-reported diabetes, adjusted for age and gender. Subclinical TB was defined as microbiologically confirmed TB without symptoms of current cough, fever, night sweats, or weight loss and symptomatic TB with at least one of these symptoms. We assessed heterogeneity using forest plots and I statistic. Missing variables were imputed through multi-level multiple imputation. This study is registered with PROSPERO (CRD42021272679).
We obtained IPD from 16 national surveys out of 21 national and five sub-national surveys identified (five in Asia and 11 in Africa, N = 740,815). Across surveys, 15.1%-56.7% of TB were subclinical (median: 38.1%). In the multivariable model, current smoking was associated with both subclinical (OR 1.67, 95% CI 1.27-2.40) and symptomatic TB (OR 1.49, 95% CI 1.34-1.66). Self-reported diabetes was associated with symptomatic TB (OR 1.67, 95% CI 1.17-2.40) but not with subclinical TB (OR 0.92, 95% CI 0.55-1.55). For alcohol drinking ≥ twice per week vs no alcohol drinking, the estimates were imprecise (OR 1.59, 95% CI 0.70-3.62) for subclinical TB and OR 1.43, 95% CI 0.59-3.46 for symptomatic TB). For the association between current smoking and symptomatic TB, I was high (76.5% (95% CI 62.0-85.4), while the direction of the point estimates was consistent except for three surveys with wide CIs.
Our findings suggest that current smokers are more likely to have both symptomatic and subclinical TB. These individuals can, therefore, be prioritised for intensified screening, such as the use of chest X-ray in the context of community-based screening. People with self-reported diabetes are also more likely to have symptomatic TB, but the association is unclear for subclinical TB.
None.
非传染性疾病(NCDs)以及非传染性疾病风险因素,如吸烟,会增加患结核病(TB)的风险。在全人群系统筛查背景下,关于这些因素与现患结核病风险的相关数据稀缺,并且非传染性疾病及非传染性疾病风险因素与结核病不同表现形式(其中约50%为无症状但细菌学检测呈阳性,即亚临床型)之间的关联也不明确。我们对国家和次国家级结核病患病率调查的个体参与者数据(IPD)进行了荟萃分析,以综合关于患有非传染性疾病或风险因素的人群中出现症状性和亚临床型结核病风险的证据,这有助于各国规划筛查活动。
在这项系统评价和IPD荟萃分析中,我们通过世界卫生组织维护的档案以及在2000年1月1日至2021年8月10日期间检索Medline和Embase,确定了低收入和中等收入国家中报告了至少一种非传染性疾病(如糖尿病)或非传染性疾病风险因素(如吸烟、饮酒)的符合条件的患病率调查。检索于2023年3月23日更新。我们使用多变量多项模型进行了单阶段荟萃分析。我们估计了当前吸烟者、饮酒者和自我报告患有糖尿病者与未患结核病者相比,亚临床型和症状性结核病的比例及比值比,并对年龄和性别进行了调整。亚临床型结核病定义为微生物学确诊的结核病,但无当前咳嗽、发热、盗汗或体重减轻症状,症状性结核病定义为具有这些症状中的至少一种。我们使用森林图和I统计量评估异质性。缺失变量通过多水平多重插补法进行插补。本研究已在国际前瞻性系统评价注册库(PROSPERO)注册(注册号:CRD42021272679)。
我们从确定的21项国家级和5项次国家级调查中的16项国家级调查中获取了IPD(亚洲5项,非洲11项,N = 740,815)。在各项调查中,15.1% - 56.7%的结核病为亚临床型(中位数:38.1%)。在多变量模型中,当前吸烟与亚临床型(比值比1.67,95%置信区间1.27 - 2.40)和症状性结核病(比值比1.49,95%置信区间1.34 - 1.66)均相关。自我报告患有糖尿病与症状性结核病相关(比值比1.67,95%置信区间1.17 - 2.40),但与亚临床型结核病无关(比值比0.92,95%置信区间0.55 - 1.55)。对于每周饮酒≥两次与不饮酒相比,亚临床型结核病的估计值不精确(比值比1.59,95%置信区间0.70 - 3.62),症状性结核病的比值比为1.43,95%置信区间0.59 - 3.46。对于当前吸烟与症状性结核病之间的关联,I值较高(76.5%(95%置信区间62.0 - 85.4)),除了三项置信区间较宽的调查外,点估计值的方向一致。
我们的研究结果表明,当前吸烟者更有可能同时患有症状性和亚临床型结核病。因此,对于这些个体可优先进行强化筛查,如在社区筛查中使用胸部X线检查。自我报告患有糖尿病者也更有可能患有症状性结核病,但与亚临床型结核病的关联尚不清楚。
无。